Royal Philips Electronics Annual Results 2000

Medical Systems
• Results for the quarter were ahead of expectations after
allowing for charges of € 44 million totally of in-process R&D
for ADAC, adjustment of ATL and MedQuist goodwill
• ATL was profitable for the whole year after goodwill, in line
with the original plan
• The completion of the acquisition of the medical business of
Agilent is expected before the end of the second quarter.
• The annual IFO shows a considerable underlying increase,
after adjusting for the above, even after increasing R&D
expenditure by € 35 million to improve our position mainly in
Magnetic Resonance and Computer Tomography
• The order book has increased on a comparable basis over a
year ago by 12% which indicates a higher sales growth rate
53